Home › INDIGOPNTS › Filing
🔔 Get instant alerts when INDIGOPNTS files quarterly results on BSE Start free trial →
Indigo Paints Limited (INDIGOPNTS)

Investor Presentation

Filed: 30 Oct 2026, 18:43 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - Standalone Q2 FY27 revenue Rs 340.5 Cr +14.1% y-y; EBITDA margin 8.9%, PAT margin 4.0% - H1 FY27 standalone revenue Rs 690.5 Cr +16.4% y-y; EBITDA margin 13.4%, PAT margin 8.0% - Q2 profitability impacted by product mix and material cost headwinds; gross margin down to 38.5% - Outlook: EBITDA margins expected to normalize in H2 FY27 with gross margin improvement - Apple Chemie growth momentum to sustain; gross margins to improve by Q3 FY27 - Capacity expansion ongoing with new plants and trial production started - Strong dealer network revival expected to drive growth and product mix improvement in H2 FY27
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 INDIGOPNTS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add INDIGOPNTS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Indigo Paints Limited

Important. The summary above is generated automatically from Indigo Paints Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.